-
1
المؤلفون: Oleksandr Kulbachuk, Deepak Bhatt, MICHAEL MILLER, Victor Gurevich, Ganna Khrystoforova, Stanislav Pekarskiy, Svitlana Naskalova, Nikolai Petrovsky, Sofia Malyutina, Christie Ballantyne, Alla Salasyuk, Andrzej Madej, Philippe Gabriel STEG, Michael Berk, Alina Gagarina, Larisa Yena, Dimitar Sajkov
المصدر: New England Journal of Medicine. 380:11-22
مصطلحات موضوعية: Male, medicine.medical_specialty, Evinacumab, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Placebo, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Risk Factors, Internal medicine, Diabetes mellitus, Secondary Prevention, medicine, Humans, 030212 general & internal medicine, Myocardial infarction, Triglycerides, Aged, Hypertriglyceridemia, business.industry, Unstable angina, Incidence, Hazard ratio, General Medicine, Middle Aged, medicine.disease, Eicosapentaenoic Acid, Cardiovascular Diseases, Cardiology, Platelet aggregation inhibitor, Drug Therapy, Combination, Female, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business, Platelet Aggregation Inhibitors, Follow-Up Studies
-
2
المؤلفون: Keith Fox, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Gianfranco Parati, Sotir Marchev, Graeme Hankey, WILLIAM HEDDLE, Claudio Marabotti, Michel GALINIER, Vladimir Zadionchenko, Roman Libis, Fernando Lanas, Malcolm Robert Macleod, Tomas Janota, Markku Kaste, Vadim Mazurov, Larisa Yena, Aleksandr DEMIN
المصدر: Circulation. 130:138-146
مصطلحات موضوعية: Male, medicine.medical_specialty, Vitamin K, medicine.drug_mechanism_of_action, Morpholines, Embolism, Factor Xa Inhibitor, Administration, Oral, Hemorrhage, Thiophenes, Double-Blind Method, Rivaroxaban, aging, anticoagulant, stroke, Physiology (medical), Internal medicine, Atrial Fibrillation, medicine, Clinical endpoint, Humans, Stroke, Aged, Aged, 80 and over, Intention-to-treat analysis, business.industry, Warfarin, Anticoagulants, Atrial fibrillation, Middle Aged, medicine.disease, Treatment Outcome, Anesthesia, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Factor Xa Inhibitors, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::545541729d7d88f857ecdb78c105121c
https://doi.org/10.1161/circulationaha.113.005008 -
3
المؤلفون: Ton Rabelink, Sadayoshi Ito, Paolo Pozzilli, Giuseppe Remuzzi, Jan Brož, Tatiana Kuznetsova, A.S. Ametov, Alexandre Persu, Renata Cífková, Vladimir Zadionchenko, Stefano Genovese, Irina Chazova, Piotr Ponikowski, JUAN ANTONIO DIVISÓN GARROTE, Larisa Yena, Krzysztof Narkiewicz, Luis M Ruilope
المساهمون: RS: NUTRIM - R2 - Gut-liver homeostasis, Interne Geneeskunde, Epidemiologie, RS: CARIM School for Cardiovascular Diseases, Pathologic Biochemistry and Physiology, Diabetes Pathology & Therapy
المصدر: Vrije Universiteit Brussel
Europe PubMed Central
New England Journal of Medicine, 364(10), 907-917. MASSACHUSETTS MEDICAL SOCIETYمصطلحات موضوعية: Adult, Male, medicine.medical_specialty, ALBUMINURIA, microalbuminuria, Adolescent, NEPHROPATHY, Tetrazoles, Blood Pressure, Coronary Disease, Type 2 diabetes, LOWERING BLOOD-PRESSURE, Placebo, DISEASE, Nephropathy, Young Adult, Double-Blind Method, Diabetes mellitus, Internal medicine, medicine, Humans, Aged, RISK, OUTCOMES, Proteinuria, HYPERTENSION, business.industry, Imidazoles, General Medicine, Middle Aged, medicine.disease, RANDOMIZED-TRIAL, Surgery, TELMISARTAN, Blood pressure, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Cardiology, Microalbuminuria, Female, LOSARTAN, medicine.symptom, Olmesartan, business, Angiotensin II Type 1 Receptor Blockers, medicine.drug, Follow-Up Studies, Glomerular Filtration Rate
-
4
المؤلفون: Jose Nicolau, Victor Aboyans, Robert Storey, Jacek Kubica, Miguel Urina, Thomas Muenzel, Andrzej Lubiński, Peter Sinnaeve, ELENA BOBESCU, Antonio Fernandez-Ortiz, Ahmed Abdel-Latif, GABRIELA CIOCA, Bassem A. Samad, Philippe Gabriel STEG, Richard Nethononda, Lesia Rasputina, Murat Kazim Ersanli, Mariya Derevyanchenko, Arie Van Dijk, Sergey Nedogoda, Silvia Valbuena-Lopez, Fernando Lanas, Tomas Janota, Bas Kietselaer, Meyer ELBAZ, Eduardo Costa Duarte Barbosa, R. David Anderson, Piotr Ponikowski, Mara Rubino, Diego Rizzotti, Andriy Bazylevych, Maya Safarova, Mikhail Statsenko, Giuseppe Patti, Fernando Manzur, Sergey Golitsyn, Larisa Yena, William Wijns, Andrzej Budaj
المساهمون: Service de cardiologie, Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Recherche Vasculaire Translationnelle (LVTS (UMR_S_1148 / U1148)), Université Paris 13 (UP13)-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), PEGASUS-TIMI 54 Steering Committee and Investigators, Université Paris Diderot - Paris 7 (UPD7)-AP-HP - Hôpital Bichat - Claude Bernard [Paris]-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Université Paris Diderot - Paris 7 (UPD7)-Université Paris 13 (UP13)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (19), pp.1791-1800. ⟨10.1056/NEJMoa1500857⟩
The New England journal of medicineمصطلحات موضوعية: Male, Risk, Acute coronary syndrome, Ticagrelor, Adenosine, Myocardial Infarction, Hemorrhage, Kaplan-Meier Estimate, Placebo, Klinikai orvostudományok, Drug Administration Schedule, Double-Blind Method, Drug Therapy, medicine, Secondary Prevention, Humans, Myocardial infarction, Aged, Aspirin, Cardiovascular Diseases, Drug Therapy, Combination, Female, Intracranial Hemorrhages, Middle Aged, Platelet Aggregation Inhibitors, Purinergic P2Y Receptor Antagonists, Medicine (all), business.industry, Hazard ratio, General Medicine, Orvostudományok, medicine.disease, 3. Good health, Anesthesia, Combination, Platelet aggregation inhibitor, Human medicine, business, TIMI, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, medicine.drug
وصف الملف: application/pdf
-
5
المؤلفون: Keith Fox, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Sotir Marchev, Graeme Hankey, WILLIAM HEDDLE, Claudio Marabotti, Michel GALINIER, Philippe Gabriel STEG, Gerald Kneller, Vladimir Zadionchenko, Roman Libis, Fernando Lanas, Malcolm Robert Macleod, Tomas Janota, Geoffrey Donnan, Dorairaj Prabhakaran, Markku Kaste, Vadim Mazurov, Larisa Yena, Ka Sing Lawrence Wong, Tissa Wijeratne, Aleksandr DEMIN, Bo Norrving
المصدر: The Lancet. Neurology. 11(4)
مصطلحات موضوعية: medicine.medical_specialty, Morpholines, Medizin, Thiophenes, law.invention, Randomized controlled trial, Double-Blind Method, Rivaroxaban, law, Internal medicine, Atrial Fibrillation, medicine, Clinical endpoint, Secondary Prevention, Humans, Multicenter Studies as Topic, Stroke, Aged, Intention-to-treat analysis, business.industry, Hazard ratio, Warfarin, Anticoagulants, Atrial fibrillation, medicine.disease, Intention to Treat Analysis, Treatment Outcome, Ischemic Attack, Transient, Cardiology, Neurology (clinical), business, medicine.drug
-
6
المؤلفون: Keith Fox, Scott Berkowitz, Konstantin Ramshev, Jacek Kubica, Miguel Urina, Sotir Marchev, Graeme Hankey, WILLIAM HEDDLE, Claudio Marabotti, Michel GALINIER, Philippe Gabriel STEG, Vladimir Zadionchenko, Fernando Lanas, Juan Mauricio Pardo-Oviedo, Malcolm Robert Macleod, Dorairaj Prabhakaran, Vadim Mazurov, Larisa Yena, Aleksandr DEMIN
المساهمون: Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai [New York] (MSSM), Division of Cardiovascular Research (EDINBURGH - DCVR), University of Edinburgh, Diener, Hans Christoph (Beitragende*r)
المصدر: New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2011, 365 (10), pp.883-91. ⟨10.1056/NEJMoa1009638⟩
The New England Journal of Medicine
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
ResearcherID
BASE-Bielefeld Academic Search Engineمصطلحات موضوعية: Male, [SDV]Life Sciences [q-bio], Embolism, Medizin, Management of atrial fibrillation, Administration, Oral, Randomization, 030204 cardiovascular system & hematology, MESH: Intention to Treat Analysis, chemistry.chemical_compound, 0302 clinical medicine, MESH: Aged, 80 and over, Rivaroxaban, Edoxaban, Atrial Fibrillation, Medicine, MESH: Double-Blind Method, 030212 general & internal medicine, MESH: Warfarin, Stroke, MESH: Treatment Outcome, Aged, 80 and over, MESH: Aged, MESH: Middle Aged, Hazard ratio, Diabetes, General Medicine, Middle Aged, MESH: Thiophenes, 3. Good health, Intention to Treat Analysis, MESH: Atrial Fibrillation, Treatment Outcome, Anesthesia, Hypertension, MESH: Administration, Oral, Female, MESH: Hemorrhage, medicine.drug, Morpholines, MESH: Morpholines, Hemorrhage, Thiophenes, MESH: Anticoagulants, MESH: Stroke, Dabigatran, 03 medical and health sciences, Double-Blind Method, Humans, Aged, HAS-BLED, MESH: Humans, business.industry, Warfarin, Anticoagulants, medicine.disease, MESH: Male, chemistry, business, MESH: Female, MESH: Embolism
وصف الملف: application/pdf
Full Text via ClinicalKey